Please upgrade your browser.
1H NMR based metabonomic approach was applied in order to monitor the alterations of plasma metabolic profile in Renal Cell Carcinoma (RCC) patients and controls
Treatment of Transitional Cell Cancer of the Renal Pelvis and Ureter in India at an Incredible Success Rate
Indian surgeons provide treatment of Transitional cell cancer of the renal pelvis and ureter with the best standards of Indian private healthcare system that can be truly described as being state-of-the-art.
MDOUTLOOK®, the oncology intelligence initiative powered by The Arcas Group, today announced results from its 3rd Annual Quick Poll research launched following this month's annual meeting of the American Society of Clinical Oncology (ASCO) in Chicago. Within one week, 281 cancer treaters from 22 countries responded, making it the first market feedback available post-ASCO.
A new probe by the British scientists into the commonest form of kidney cancer have unveiled a batch of new gene mutations linked to it, suggesting even this apparently "straightforward" cancer type can be divided into subtypes requiring tailored treatment.
The company is providing a preliminary update on Trial 103 (the first stage of the Phase II program) in which MGCD265 is administered in combination with either erlotinib (Tarceva®) or docetaxel (Taxotere®) in solid tumor patients.
Kidney problems are the second serious condition linked to the cancer drug. Last year it was found that some patients on Avastin were at elevated risk of intestinal perforations.
Longtime Howard County football coach Ken Hovet died Monday night after fighting kidney cancer for several months. He was 49.
AVEO Pharmaceuticals Human Response Platform and Proprietary Mouse Models Featured in Nature Reviews Cancer
Tivozanib is currently being investigated in a global, randomized Phase 3 clinical trial called TIVO-1 comparing tivozanib to sorafenib in advanced kidney cancer, as well as additional clinical studies in other solid tumor types.
Laparo-endoscopic single-site (LESS) radical nephrectomy with renal vein thrombectomy: initial report
By combining trocar sites and extraction incision, Laparo-endoscopic Single-site Surgery (LESS) may provide less morbidity than traditional laparoscopy. Concerns continue about LESS for locally advanced tumors. We present our experience with LESS-radical nephrectomy with renal vein thrombectomy (LESS-RN-RVT).
MicroRNA profiling of clear cell renal cell carcinoma by whole-genome small RNA deep sequencing of paired frozen and formalin-fixed, paraffin-embedded tissue specimens
Renal cell carcinoma (RCC) is one of the leading causes of cancer mortality. Characterization of microRNA (miRNA) expression of RCC will help disclose new pathogenic pathways in tumourigenesis and progression and may lead to the development of molecular biomarkers and target-specific therapies for diagnosis, prognostication and treatment.
|Powered by NeonCRM|